±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 13:30~13:55 Treatment of IgA nephropathy: Review of guideline and summary of recent studies °¼®ÈÖ(¿µ³²ÀÇ´ë) ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 13:55~14:20 Primary MGN: Recent insights into pathogenesis and treatment ±ÇÇõ¿ë(BHSÇѼº´¿ø) ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 14:20~14:45 Potassium control in CKD and ESRD: The old, the current, and the future °°Ç¿ì(´ë±¸°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 14:45~15:10 Direct oral anticoagulation in advanced kidney disease: An update ±èÅÂÈñ(ÀÎÁ¦ÀÇ´ë) ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 15:25~15:50 What¡¯s new in DKD? ¹ÚöÈÖ(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 15:50~16:15 Guideline for preventing of infections in hemodialysis center ÀÌ¿µ±â(ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 16:15~16:40 What¡¯s the better choice between HD with medium cut-off dialyzer & on-line HDF? Á¶ÀåÈñ(°æºÏÀÇ´ë) ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 16:40~17:05 Virtual reality-based training in Nephrology: has the future arrived? ±è¼º±Õ(ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 17:20~17:45 Disaster management: lessons learned from MERS and earthquake À¯°æµ·(µ¿±¹ÀÇ´ë) ±³À°½Ã°£ 11-17 ½Ãû°¢½Ç 17:45~18:10 BP management in CKD patients: a review of recent guidelines ÀåÇÏ´Ï(°æ»óÀÇ´ë)